hfpef tirzepatide cuts heart failure risk in patients tirzepatide hfpef 🧬 New data

Contrave is an FDA-approved medication that reduces hunger and helps to control cravings and is designed to help overweight individuals and those struggling with obesity to lose weight and maintain that weight loss

Age-related vision loss doesnt just start in the eyes

[1] [3] This is particularly relevant for post-bariatric patients, who may already have altered biliary physiology

The pressing question remains: how transformative will the introduction of these new weight loss drugs be across the broader healthcare landscape

Consuming sufficient protein helps maintain follicle function

Dynapenic abdominal obesity as a predictor of worsening disability, hospitalization, and mortality in older adults: results from the InCHIANTI study